slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 104,371-104,400
Pages 10,126
Rows per page 30
Component
104,371-104,400 of 303,780
83
The slide uses a two-column layout to contrast deleveraging performance with debt structure.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
85
The slide uses a dark blue background with a list of four key financial metrics and their corresponding targets.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
86
The chart uses a waterfall structure to bridge the 2025 actual revenue to the 2028 expected revenue.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
87
The chart shows a margin expansion from 15.8% to 20% over the period.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
88
The slide uses a table to contrast financial performance and outlooks for Protein Solutions and Prepared Food and Beverage Solutions.2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
89
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
90
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
91
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
92
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
93
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
94
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
95
Includes detailed footnotes explaining the nature of adjustments (financing income, pension expense, restructuring, M&A costs, D&A).2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
96
2026 Investor Day2026 Investor Day · JBT Marel
Consulting deck Strategy consulting Beat · Action1 hit
01
2026 Investor Deck2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting 1 hit
02
Includes specific disclaimer about ivonescimab regulatory status and copyright information.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting 1 hit
05
The slide uses a scientific illustration to explain the molecular mechanism of a bispecific antibody.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
06
The table uses a visual bar representation for clinical trial phases (1/1b, 2, 3).2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · ProductLoop · Cost Of Inaction1 hit
09
The slide presents clinical trial data for Ivonescimab in NSCLC, showing consistent HR improvements across different patient populations.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
11
The slide uses a checkmark visual to indicate positive outcomes for each clinical question posed.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
12
The slide uses a timeline framework to communicate upcoming clinical trial readouts and regulatory events.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Loop · Cost Of Inaction1 hit
13
The slide highlights a strong liquidity position with significant cash and zero debt.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · FinancialsLoop · Cost Of Inaction1 hit
14
The slide uses a visual flow to aggregate market sizes and point toward future growth areas.2026 Investor Deck · Summit Therapeutics
Consulting deck Strategy consulting Beat · Market SizeLoop · Cost Of Inaction1 hit
01
Includes CEO quote and segment-specific product/category icons.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
02
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
04
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
05
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting 1 hit
06
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Team1 hit
08
The slide uses a grid layout to showcase product logos under three main therapeutic pillars.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Solution1 hit
09
2026 Q1 Earnings2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Solution1 hit
10
The slide uses a grid layout to showcase product logos under three main therapeutic pillars.2026 Q1 Earnings · Johnson & Johnson
Consulting deck Strategy consulting Beat · Solution1 hit